Gurunathan, Sanjay
Sanofi (United States)
3 papers on CoChatORCID 0009-0007-7241-6370
Most cited papers
- Verified
Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
DiazGranados, C. A., Dunning, A. J., Kimmel, M., Kirby, D., Treanor, J., Collins, A., Pollak, R., Christoff, J., Earl, J., Landolfi, V., et al. (2014) · New England Journal of Medicine
Influenza Virus Research StudiesRespiratory viral infections research
Cited by 876
- Verified
The promise of mRNA vaccines: a biotech and industrial perspective
Jackson, N. A. C., Kester, K. E., Casimiro, D., Gurunathan, S., & DeRosa, F. (2020) · npj Vaccines
RNA Interference and Gene DeliverySARS-CoV-2 and COVID-19 Research
Cited by 498
- Verified
Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene
Mei, Q., Gurunathan, S., Masur, H., & Kovacs, J. A. (1998) · The Lancet
Pneumocystis jirovecii pneumonia detection and treatmentPneumonia and Respiratory Infections
Cited by 108
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free